Data / Form D filings / Magnus Medical, Inc.
Magnus Medical, Inc.: Form D filings
Magnus Medical, Inc., a biotechnology company in Burlingame, CA, filed 3 Form D notices with the SEC between 2025 and 2026. The latest, on May 26, 2026, reports $49 million sold of a $77 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1350 OLD BAYSHORE HWY, SUITE 600, Burlingame, CA, 94010
- Phone
- (415) 231-7407
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2057312
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | Amendment | $77,000,000 | $49,030,035 | $27,969,965 | 10 | May 1, 2025 | sec.gov |
| May 12, 2025 | New notice | $77,000,000 | $23,683,674 | $53,316,326 | 6 | May 1, 2025 | sec.gov |
| Mar 14, 2025 | New notice | $58,986,010 | $40,302,337 | $18,683,673 | 10 | Feb 7, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Achal Achrol | Executive Officer, Director | |
| Andrew Firlik | Director | |
| Heath Lukatch | Director | |
| Brandon Bentzley | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 25, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Magnus Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.